ImmunityBio is a biotechnology business based in the US. ImmunityBio stocks (IBRX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.75 – an increase of 15.55% over the previous week. ImmunityBio employs 703 staff and has a trailing 12-month revenue of around $586,000.
How to buy ImmunityBio stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – IBRX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
Interactive Brokers
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
ImmunityBio stock price (NASDAQ:IBRX)
Use our graph to track the performance of IBRX stocks over time.ImmunityBio shares at a glance
Latest market close | $2.75 |
---|---|
52-week range | $1.21 - $7.80 |
50-day moving average | $2.55 |
200-day moving average | $4.11 |
Wall St. target price | $4.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.90 |
Buy Immunitybio stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy ImmunityBio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
ImmunityBio price performance over time
Historical closes compared with the close of $2.75 from 2023-05-31
1 week (2023-05-26) | 8.27% |
---|---|
1 month (2023-05-02) | -10.71% |
3 months (2023-03-02) | 35.47% |
6 months (2022-12-02) | -55.86% |
1 year (2022-06-02) | -17.66% |
---|---|
2 years (2021-06-02) | -84.22% |
3 years (2020-05-29) | N/A |
5 years (2018-05-29) | N/A |
ImmunityBio financials
Revenue TTM | $586,000 |
---|---|
Gross profit TTM | $240,000 |
Return on assets TTM | -62.46% |
Return on equity TTM | 0% |
Profit margin | 0% |
Book value | $-1.21 |
Market capitalisation | $1.1 billion |
TTM: trailing 12 months
ImmunityBio share dividends
We're not expecting ImmunityBio to pay a dividend over the next 12 months.
ImmunityBio share price volatility
Over the last 12 months, ImmunityBio's shares have ranged in value from as little as $1.21 up to $7.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ImmunityBio's is -0.3371. This would suggest that ImmunityBio's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, ImmunityBio has bucked the trend.
ImmunityBio overview
ImmunityBio, Inc. , a clinical-stage biotechnology company, engages in developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases in the United States and Europe. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion protein N-803, vaccine technologies, toll-Like receptor activating adjuvants, natural killer cells, and damage-associated molecular patterns inducers. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute and Amyris, Inc. ; and license agreements with LadRx Corporation, GlobeImmune, Inc. , Access to Advanced Health Institute, 3M Innovative Properties Company, Sanford Health, Shenzhen Beike Biotechnology Co.
Stocks similar to ImmunityBio
ImmunityBio in the news
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
ImmunityBio to Participate in the Jefferies Global Healthcare Conference
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing

How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…More guides on Finder
-
Best bad credit loans in PEI
Compare some of the best bad credit loans in PEI.
-
Credito review
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
-
5 apps like Bree in Canada
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
-
Debt Relief Canada (reliefcanada.ca) review
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
-
Desjardins Online Brokerage (Disnat) review 2023
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
-
Guide to finding the best prepaid card in Canada in June 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
-
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
-
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
-
RightRide review
Your guide to buying and financing a car in Canada with RightRide.
-
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.